| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,508 |
2,157 |
$148K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,015 |
2,580 |
$133K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
433 |
375 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
1,061 |
939 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
405 |
229 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54 |
52 |
$543.14 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
151 |
133 |
$520.31 |
| 90674 |
|
33 |
29 |
$361.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
116 |
100 |
$67.97 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
12 |
$37.02 |
| 3074F |
|
170 |
157 |
$0.39 |
| 3078F |
|
132 |
122 |
$0.22 |
| 3046F |
|
112 |
102 |
$0.06 |
| 1159F |
|
14 |
14 |
$0.02 |
| 2022F |
|
329 |
303 |
$0.02 |
| 1126F |
|
16 |
16 |
$0.02 |
| 3060F |
|
56 |
46 |
$0.01 |
| 0518F |
|
306 |
277 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
41 |
38 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
45 |
41 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
12 |
12 |
$0.00 |
| 1101F |
|
551 |
505 |
$0.00 |
| 1036F |
|
970 |
865 |
$0.00 |
| 3017F |
|
723 |
643 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
93 |
88 |
$0.00 |
| 3008F |
|
12 |
12 |
$0.00 |
| 2000F |
|
15 |
14 |
$0.00 |